Platelet concentrates: reducing the risk of transfusion-transmitted bacterial infections

References

• Soldan K, Davison K, Dow B. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Euro Surveill. 2005;10:17–19.
   PubMedGoogle Scholar
• Sazama K. Reports on 355 transfusion-associated deaths: 1976 through 1985. Transfusion. 1990;30:583–590.
   PubMed Web of Science ®Google Scholar
• Walther-Wenke G, Schrezenmeier H, Deitenbeck R, et al. Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportion of transfused units, and clinical follow-up. Ann Hematol. 2010;89:83–91.
   PubMed Web of Science ®Google Scholar
• de Korte D, Marcelis JH, Soeterboek AM. Determination of the degree of bacterial contamination of whole-blood collections using an automated microbe-detection system. Transfusion. 2001;41:815–818.
   PubMed Web of Science ®Google Scholar
• Rhame FS, Root RK, MacLowry JD, Dadisman TA, Bennett JV. Salmonella septicemia from platelet transfusions. Study of an outbreak traced to a hematogenous carrier of Salmonella cholerae-suis. Ann Intern Med. 1973;78:633–641.
   PubMed Web of Science ®Google Scholar
• Heltberg O, Skov F, Gerner-Smidt P, et al. Nosocomial epidemic of Serratia marcescens septicemia ascribed to contaminated blood transfusion bags. Transfusion. 1993;33:221–227.
   Web of Science ®Google Scholar
• Goldman M, Blajchman MA. Blood product-associated bacterial sepsis. Transfus Med Rev. 1991;5:73–83.
   PubMedGoogle Scholar
• Bland LA, Villarino ME, Arduino MJ, et al. Bacteriologic and endotoxin analysis of salvaged blood used in autologous transfusions during cardiac operations. J Thorac Cardiovasc Surg. 1992;103:582–588.
   Web of Science ®Google Scholar
• Ness PM, Perkins HA. Transient bacteremia after dental procedures and other minor manipulations. Transfusion. 1980;20:82–85.
   PubMed Web of Science ®Google Scholar
• Hockett RN, Loesche WJ, Sodeman TM. Bacteraemia in asymptomatic human subjects. Arch Oral Biol. 1977;22:91–98.
   PubMed Web of Science ®Google Scholar
• Tipple MA, Bland LA, Murphy JJ, et al. Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica. Transfusion. 1990;30:207–213.
   PubMed Web of Science ®Google Scholar
• Stenhouse MA, Milner LV. Yersinia enterocolitica. A hazard in blood transfusion. Transfusion. 1982;22:396–398.
   PubMed Web of Science ®Google Scholar
• Guinet F, Carniel E, Leclercq A. Transfusion-transmitted Yersinia enterocolitica sepsis. Clin Infect Dis. 2011;53:583–591.
   PubMed Web of Science ®Google Scholar
• Bottone EJ. Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev. 1997;10:257–276.
   PubMed Web of Science ®Google Scholar
• Prentice M. Transfusing Yersinia enterocolitica. BMJ. 1992;305:663–664.
   PubMed Web of Science ®Google Scholar
• [No authors listed]. From the Centers for Disease Control and Prevention. Red blood cell transfusions contaminated with Yersinia enterocolitica – United States, 1991–1996, and initiation of a national study to detect bacteria-associated transfusion reactions. JAMA. 1997;278:196–197.
   Web of Science ®Google Scholar
• Martich GD, Boujoukos AJ, Suffredini AF. Response of man to endotoxin. Immunobiology. 1993;187:403–416.
   PubMed Web of Science ®Google Scholar
• Jafari M, Forsberg J, Gilcher RO, et al. Salmonella sepsis caused by a platelet transfusion from a donor with a pet snake. N Engl J Med. 2002;347:1075–1078.
   PubMed Web of Science ®Google Scholar
• Bhanji S, Williams B, Sheller B, Elwood T, Mancl L. Transient bacteremia induced by toothbrushing: a comparison of the Sonicare toothbrush with a conventional toothbrush. Pediatr Dent. 2002;24:295–299.
   PubMedGoogle Scholar
• Maibach H, Aly R. Skin Microbiology: Relevance to Clinical Infection. New York: Springer; 1981.
   Google Scholar
• Eder AF, Kennedy JM, Dy BA, et al. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004–2006). Transfusion. 2007;47:1134–1142.
   PubMed Web of Science ®Google Scholar
• Munksgaard L, Albjerg L, Lillevang ST, Gahrn-Hansen B, Georgsen J. Detection of bacterial contamination of platelet components: six years’ experience with the BacT/ALERT system. Transfusion. 2004;44:1166–1173.
   PubMed Web of Science ®Google Scholar
• de Korte D, Curvers J, de Kort W, et al. Effects of skin disinfection method, deviation bag and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion. 2006;46:476–485.
   PubMed Web of Science ®Google Scholar
• Perez P, Salmi LR, Follea G, et al. Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study. Transfusion. 2001;41:862–872.
   Web of Science ®Google Scholar
• Roth VR, Kuehnert MJ, Haley NR, et al. Evaluation of a reporting system for bacterial contamination of blood components in the United States. Transfusion. 2001;41:1486–1492.
   PubMed Web of Science ®Google Scholar
• Walther-Wenke G, Wirsing von Konig CH, Däubener W, et al. Monitoring bacterial contamination of blood components in Germany: effect of contamination reduction measures. Vox Sang. 2011;100:359–366.
   Web of Science ®Google Scholar
• Goldman M, Lee JH, Blajchman MA. . Skin antisepsis and initial aliquot diversion. In: Brecher MA, editor. Bacterial and Parasitic Contamination of Blood Components. Bethesda (MD): AABB; 2003:31–56.
   Google Scholar
• McDonald CP, Lowe P, Roy A, et al. Evaluation of donor arm disinfection techniques. Vox Sang. 2001;80:135–141.
   PubMed Web of Science ®Google Scholar
• McDonald CP, Roy A, Mahajan P, Smith R, Charlett A, Barbara JA. Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang. 2004;86:178–182.
   PubMed Web of Science ®Google Scholar
• McDonald CP. Interventions implemented to reduce the risk of transmission of bacteria by transfusion in the English National Blood Service. Transfus Med Hemother. 2011;38:255–258.
   PubMed Web of Science ®Google Scholar
• McDonald C, McGuane S, Thomas J, et al. A novel rapid and effective donor arm disinfection method. Transfusion. 2010;50:53–58.
   PubMed Web of Science ®Google Scholar
• Ramirez-Arcos S, Goldman M. Skin disinfection methods: prospective evaluation and postimplementation results. Transfusion. 2010;50:59–64.
   Web of Science ®Google Scholar
• Benjamin RJ, Dy B, Warren R, Lischka M, Eder AF. Skin disinfection with a single-step 2% chlorhexidine swab is more effective than a two-step povidone-iodine method in preventing bacterial contamination of apheresis platelets. Transfusion. 2011;51:531–538.
   Web of Science ®Google Scholar
• Olthuis H, Puylaert C, Verhagen C, Valk L. Method for removal of contaminating bacteria during venapuncture [abstract]. Poster presented at: Fifth Regional Congress of the International Society of Blood Transfusion; July 2–5, 1995; Venice.
   Google Scholar
• Gibson AP, Norris W. Skin fragments removed by injection needles. Lancet. 1958;2:983–985.
   Google Scholar
• Blajchman MA. Bacterial contamination and proliferation during the storage of cellular blood products. Vox Sang. 1998;74S:155–159.
   Web of Science ®Google Scholar
• Bruneau C, Perez P, Chassaigne M, et al. Efficacy of a new collection procedure for preventing bacterial contamination of whole-blood donations. Transfusion. 2001;41:74–81.
   PubMed Web of Science ®Google Scholar
• Wagner SJ, Robinette D, Friedman LI, Miripol J. Diversion of initial blood flow to prevent whole-blood contamination by skin surface bacteria: an in vitro model. Transfusion. 2000;40:335–338.
   Web of Science ®Google Scholar
• de Korte D, Marcelis JH, Verhoeven AJ, Soeterboek AM. Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections. Vox Sang. 2002;83:13–16.
   PubMed Web of Science ®Google Scholar
• Benjamin RJ, Kline L, Dy BA, et al. Bacterial contamination of whole-blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross. Transfusion. 2008;48:2348–2355.
   Web of Science ®Google Scholar
• Eder AF, Kennedy JM, Dy BA, et al. Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion. 2009;49:1554–1563.
   PubMed Web of Science ®Google Scholar
• Nightingale MJ, Beard MJ, Bennett J, Hambleton R, Ramskill S, Thomas S. The donor line break cannula: effect on the donation process, blood component quality and transfusion microbiology testing of an important new blood bag safety feature. Transfus Med. 2013;23:219–225.
   Web of Science ®Google Scholar
• te Boekhorst TA, Beckers EA, Vos M, Vermeij H, van Rhenen DJ. Clinical significance of bacteriologic screening in platelet concentrates. Transfusion. 2005;45:514–519.
   Web of Science ®Google Scholar
• Koopman MM, van’t Ende E, Lieshout-Krikke R, Marcelis J, Smid WM, de Korte D. Bacterial screening of platelet concentrates: results of 2 years active surveillance of transfused positive cultured units released as negative to date. Vox Sang. 2009;97:355–357.
   Web of Science ®Google Scholar
• Brecher ME, Heath DG, Hay SN, Rothenberg SJ, Stutzman LC. Evaluation of a new generation of culture bottle using an automated bacterial culture system for detecting nine common contaminating organisms found in platelet components. Transfusion. 2002;42:774–779.
   PubMed Web of Science ®Google Scholar
• Brecher ME, Means N, Jere CS, Heath DG, Rothenberg SJ, Stutzman LC. Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organisms. Transfusion. 2001;41:477–482.
   PubMed Web of Science ®Google Scholar
• Brecher ME, Hay SN, Rothenberg SJ. Validation of BacT/ALERT plastic culture bottles for use in testing of whole-blood-derived leukoreduced platelet-rich-plasma-derived platelets. Transfusion. 2004;44:1174–1178.
   Web of Science ®Google Scholar
• Pearce S, Rowe GP, Field SP. Screening of platelets for bacterial contamination at the Welsh Blood Service. Transfus Med. 2011;21:25–32.
   Web of Science ®Google Scholar
• Benjamin RJ, Dy B, Perez J, Eder AF, Wagner SJ. Bacterial culture of apheresis platelets: a mathematical model of the residual rate of contamination based on unconfirmed positive results. Vox Sang. 2014;106:23–30.
   PubMed Web of Science ®Google Scholar
• Stormer M, Arroyo A, Brachert J, et al. Establishment of the first international repository for transfusion-relevant bacteria reference strains: ISBT working party transfusion-transmitted infectious diseases (WP-TTID), subgroup on bacteria. Vox Sang. 2012;102:22–31.
   Web of Science ®Google Scholar
• Jacobs MR, Good CE, Lazarus HM, Yomtovian RA. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis. 2008;46:1214–1220.
   PubMed Web of Science ®Google Scholar
• Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167–193.
   PubMed Web of Science ®Google Scholar
• Jacobs MR, Smith D, Heaton WA, Zantek ND, Good CE. Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test. Transfusion. 2011;51:2573–2582.
   Web of Science ®Google Scholar
• Jacobs MR, Bajaksouzian S, Yomtovian R, et al. Detection of bacteria in leukocyte-reduced whole blood derived platelet units using the Immunetics BacTx test [abstract]. Transfusion. 2010;50S:194A.
   Google Scholar
• Dunbar NM, Kreuter JD, Marx-Wood CR, Dumont LJ, Szczepiorkowski ZM. Routine bacterial screening of apheresis platelets on day 4 using a rapid test: a 4-year single-center experience. Transfusion. 2013;53:2307–2313.
   Web of Science ®Google Scholar
• Vollmer T, Hinse D, Schottstedt V, et al. Inter-laboratory comparison of different rapid methods for the detection of bacterial contamination in platelet concentrates. Vox Sang. 2012;103:1–9.
   Web of Science ®Google Scholar
• Rood IG, Pettersson A, Savelkoul PH, de Korte D. Development of a reverse transcription-polymerase chain reaction assay for eubacterial RNA detection in platelet concentrates. Transfusion. 2010;50:1352–1358.
   Web of Science ®Google Scholar
• Rood IG, Pettersson A, Savelkoul PH, de Korte D. Performance and suitability of polymerase chain reaction for early detection of bacteria in platelet concentrates. Transfusion. 2011;51:2006–2011.
   Web of Science ®Google Scholar
• Sireis W, Rüster B, Daiss C, et al. Extension of platelet shelf life from 4 to 5 days by implementation of a new screening strategy in Germany. Vox Sang. 2011;101:191–199.
   Web of Science ®Google Scholar
• Vollmer T, Dreier J, Schottstedt V, et al. Detection of bacterial contamination in platelet concentrates by a sensitive flow cytometric assay (BactiFlow): a multicentre validation study. Transfus Med. 2012;22:262–271.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Sireis W, Seifried E. Implementation of bacterial detection methods into blood donor screening – overview of different technologies. Transfus Med Hemother. 2011;38:259–265.
   Web of Science ®Google Scholar
• Vollmer T, Kleesiek K, Dreier J. Detection of bacterial contamination in platelet concentrates using flow cytometry and real-time PCR methods. Methods Mol Biol. 2013;943:91–103.
   Google Scholar
• Dumont LJ, Kleinman S, Murphy JR, et al. Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion. 2010;50:589–599.
   PubMed Web of Science ®Google Scholar
• Karssing W, de Wildt-Eggen J, van Zeelst J, et al. Frequency of false-negative cultures in screening of platelet concentrates for bacterial contamination [abstract]. Transfusion. 2010;50S:31A.
   Google Scholar
• Murphy WG, Foley M, Doherty C, et al. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang. 2008;95:13–19.
   PubMed Web of Science ®Google Scholar
• Ramirez-Arcos S, Kou Y, Mastronardi C, Perkins H, Goldman M. Bacterial screening of outdated buffy coat platelet pools using a culture system and a rapid immunoassay. Transfusion. 2011;51:2566–2572.
   Web of Science ®Google Scholar
• de Korte D. . Implementation of a screening system for bacteria detection. In: Brecher MA, editor. Bacterial and Parasitic Contamination of Blood Components. Bethesda (MD): AABB; 2003;85–107.
   Google Scholar
• Harm SK, Delaney M, Charapata M, Aubuchon JP, Triulzi DJ, Yazer MH. Routine use of a rapid test to detect bacteria at the time of issue for nonleukoreduced, whole blood-derived platelets. Transfusion. 2013;53:843–850.
   Web of Science ®Google Scholar
• Palavecino EL, Yomtovian RA, Jacobs MR. Detecting bacterial contamination in platelet products. Clin Lab. 2006;52:443–456.
   Web of Science ®Google Scholar
• Leydold SM, Farcet MR, Kindermann J, et al. Chikungunya virus and the safety of plasma products. Transfusion. 2012;52:2122–2130.
   Web of Science ®Google Scholar
• Stramer SL, Linnen JM, Carrick JM, et al. Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion. 2012;52:1657–1666.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Geilenkeuser WJ, Sireis W, Seifried E, Hourfar K. Emerging pathogens – how safe is blood? Transfus Med Hemother. 2014;41:10–17.
   Web of Science ®Google Scholar
• Alter HJ, Stramer SL, Dodd RY. Emerging infectious diseases that threaten the blood supply. Semin Hematol. 2007;44:32–41.
   PubMed Web of Science ®Google Scholar
• Stramer SL, Hollinger FB, Katz LM, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion. 2009;49 Suppl 2:1S–29S.
   Google Scholar
• Klamroth R, Gottstein S, Orlovic M, Heinrichs C. Long-term efficacy and safety of a pasteurized, plasma-derived factor VIII concentrate (Beriate P) in patients with haemophilia A. Thromb Res. Epub November 17, 2013.
   Google Scholar
• Unger U, Poelsler G, Modrof J, Kreil TR. Virus inactivation during the freeze-drying processes as used for the manufacture of plasma-derived medicinal products. Transfusion. 2009;49:1924–1930.
   PubMed Web of Science ®Google Scholar
• Caballero S, Diez JM, Belda FJ, et al. Robustness of nanofiltration for increasing the viral safety margin of biological products. Biologicals. 2014;42:79–85.
   PubMed Web of Science ®Google Scholar
• Hofstra JJ, Kleine BI, van Twuywer E, et al. Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety. Clin Immunol. 2012;142:280–290.
   PubMed Web of Science ®Google Scholar
• Prowse CV. Component pathogen inactivation: a critical review. Vox Sang. 2013;104:183–199.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Kapzrak B, Pfeiffer HU, Henschler R, Sireis W, Seifried E. Efficiency of pathogen inactivation system INTERCEPT under experimental conditions [abstract]. Vox Sang. 2011;101 Suppl 1:226–227.
   Google Scholar
• Goodrich RP, Gilmour D, Hovenga N, Keil SD. A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns. Transfusion. 2009;49:1205–1216.
   PubMed Web of Science ®Google Scholar
• Kerkhoffs JL, van Putten WL, Novotny VM, et al. Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. Br J Haematol. 2010;150:209–217.
   PubMed Web of Science ®Google Scholar
• van der Meer PF, Kerkhoffs JL, Curvers J, et al. In vitro comparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for an in vitro rating system. Vox Sang. 2010;98:517–524.
   Web of Science ®Google Scholar
• Schubert P, Coupland D, Culibrk B, Goodrich RP, Devine DV. Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment. Transfusion. 2013;53:3164–3173.
   PubMed Web of Science ®Google Scholar
• Cookson P, Thomas S, Marschner S, Goodrich R, Cardigan R. In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days. Transfusion. 2012;52:983–994.
   Web of Science ®Google Scholar
• Cid J, Escolar G, Lozano M. Therapeutic efficacy of platelet components treated with amotosalen and ultraviolet A pathogen inactivation method: results of a meta-analysis of randomized controlled trials. Vox Sang. 2012;103:322–330.
   PubMed Web of Science ®Google Scholar
• Janssen MP, van der Poel CL, Buskens E, Bonneux L, Bonsel GJ, van Hout BA. Costs and benefits of bacterial culturing and pathogen reduction in the Netherlands. Transfusion. 2006;46:956–965.
   PubMed Web of Science ®Google Scholar
• Schrezenmeier H, Walther-Wenke G, Müller TH, et al. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion. 2007;47:644–652.
   PubMed Web of Science ®Google Scholar
• Andreu G, Vasse J, Sandid I, Tardivel R, Semana G. Use of random versus apheresis platelet concentrates. Transfus Clin Biol. 2007;14:514–521.
   PubMed Web of Science ®Google Scholar
• Vamvakas EC. Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks. Transfusion. 2009;49:2743–2758.
   PubMed Web of Science ®Google Scholar